21 Sep 2026 Regulated information: Fagron increases share capital through exercise subscription rights Download
30 Jul 2026 Regulated information: Fagron delivers strong H1 2026 performance with 16% topline growth and reiterates FY 2026 guidance Download
15 May 2026 Fagron update on FDA communication regarding the November 2025 inspection at Boston Download